NAD+ Injections vs NAD+ IV: Which Delivery Fits You?

If you have searched for NAD+ in New York, you have probably noticed that the same molecule is offered in two very different packages. One is a slow infusion that can take a couple of hours in a reclining chair. The other is a small subcutaneous shot that takes a minute. Both are called NAD therapy. Both are marketed with similar language about energy, focus, and healthy aging. And the people selling them rarely explain why you might pick one over the other.

The two formats are not interchangeable. They differ in dose, in how the body meets the molecule, in comfort, in cost, and in what a reasonable person should expect from each. This guide lays out those differences plainly, describes what the research does and does not support, and offers a way to decide.

A quick refresher on what NAD+ is

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme found in every cell. It takes part in hundreds of reactions, particularly those involved in turning food into usable energy inside mitochondria. It is also a required fuel for sirtuins and PARP enzymes, which are involved in DNA repair and cellular stress responses.

Levels of NAD+ appear to decline with age in several human tissues, and that observation is the foundation of the current interest. The reasoning is straightforward: if cellular NAD+ falls as we get older, perhaps restoring it would support function. The reality is more complicated. Lower NAD+ in aging tissue is well documented in animal studies, and human data are more limited. Whether raising blood or tissue levels translates to meaningful clinical benefit in healthy adults remains an open question under active investigation.

For a broader look at the potential upside, our article on the anti-aging benefits of NAD therapy covers the proposed mechanisms in more detail. Here we focus on the practical question of route of delivery.

Why the route matters at all

The body treats NAD+ differently depending on how it arrives. Swallowed NAD+ itself is largely broken down in the gut, which is why oral products usually contain precursors such as nicotinamide riboside or nicotinamide mononucleotide instead.

Bypassing the gut, through either an intravenous infusion or a subcutaneous injection, delivers the molecule into the bloodstream or nearby tissue without first passing through digestion and the liver. From there, cells take up the breakdown products, mainly nicotinamide and related metabolites, and rebuild NAD+ internally. In other words, even when you receive NAD+ directly, cells largely reassemble their own.

The differences between an infusion and an injection come down to volume, speed, and dose.

The IV infusion, in detail

An NAD+ infusion delivers the compound into a vein through a small catheter, usually in the arm, diluted in saline and given slowly.

Dose. Infusions typically range from a few hundred milligrams up to 1000 milligrams or more per session, depending on the protocol. This is the main reason they are used for higher dose approaches.

Time. Because rapid delivery can cause unpleasant effects, the drip is run slowly. Depending on the dose, sessions often last from one to four hours. A shorter session generally means a lower dose or a faster rate, and the second option is where discomfort creeps in.

Common sensations. Many people notice flushing, warmth, chest tightness, abdominal cramping, nausea, or a general feeling of pressure during the infusion, especially if the rate is too fast. These effects usually ease immediately when the drip is slowed. A skilled nurse or physician adjusts the speed to your comfort, which is one reason supervision matters.

Monitoring. Because the drip is in a vein, a clinician can observe your response in real time, adjust the rate, and stop if needed. Access to a clinical setting also allows for combining infusions with other nutrients when appropriate, although not everyone wants that.

Cost. Per session, infusions are the more expensive option, reflecting the dose, the clinical time, and the chair time.

Practicalities. A session is a block of your day. Many people bring a laptop or a book. Some feel energized afterward, some feel tired, and most feel fine to return to normal activity, though individual responses vary.

If you are curious how an NAD infusion compares to a generic vitamin drip, we cover that separately in NAD IV therapy versus a standard vitamin drip.

The subcutaneous injection, in detail

An NAD+ injection uses a small needle to place the compound just under the skin, usually in the abdomen or thigh. It is the same style of injection used for insulin or many peptide medications.

Dose. Injections generally contain a smaller dose than an infusion, commonly in the range of tens to a couple hundred milligrams, though products and protocols differ. The volume that can comfortably be placed under the skin is limited.

Time. The injection itself takes seconds. Some protocols use it daily or several times per week; others use it weekly.

Common sensations. Stinging or burning at the injection site is common, and some people notice redness, mild swelling, or a bruise. Flushing, nausea, or a warm feeling can occur, particularly after larger doses. Rotating sites and injecting slowly can reduce discomfort.

Absorption. Subcutaneous delivery is slower than intravenous, since the compound has to move from the tissue into circulation. That gentler pace tends to lessen the acute sensations of an infusion, and the lower dose is part of why.

Cost. Per dose, injections are cheaper. Over a month, though, a frequent injection schedule can add up, so total cost depends on the protocol.

Practicalities. Some clinics teach patients to self-inject at home. This adds convenience but also responsibility: correct storage, sterile technique, dosing accuracy, and a reliable source of product. Home use without medical oversight raises the stakes.

Side by side

No single row settles the choice, but together they show the tradeoff: infusions concentrate more into fewer, longer sessions, and injections spread smaller amounts across more frequent, shorter ones.

What the evidence actually says

This is the section that separates honest practices from enthusiastic ones.

Human research on raising NAD+ with precursors, mainly nicotinamide riboside and nicotinamide mononucleotide, shows that blood NAD+ levels can increase with oral dosing. Whether this leads to meaningful improvements in strength, insulin sensitivity, vascular function, or other outcomes is mixed across trials, and results vary by population and dose. Many studies are small and short.

For intravenous NAD+ specifically, the published human evidence is thinner. It has been used in addiction medicine and in some clinical settings, and there are case series and observational reports, but large randomized trials showing durable benefits for healthy aging are lacking. For subcutaneous NAD+, evidence is thinner still.

That does not mean the treatments are without value. Many patients report subjective improvement in energy, clarity, or recovery, and clinical experience is a legitimate form of information. It does mean that claims about reversing aging, curing fatigue, or transforming biology should be treated with skepticism. A responsible clinician sets expectations honestly: this is a supportive therapy with plausible biology, variable individual response, and ongoing research.

It is also worth knowing that NAD+ products for injection or infusion are typically compounded, and NAD+ is not approved by the FDA as a treatment for aging. The source and quality of the compound matter enormously. Working with a licensed physician who uses reputable compounding pharmacies is not a formality; it is the main safeguard.

What a typical course looks like from the inside

It helps to picture the calendar, because the practical experience differs more than the pharmacology does.

An infusion-based course is usually front-loaded. A patient might come in for a series of sessions over one to two weeks, then space visits out to monthly or as-needed maintenance. Each visit begins with a brief check-in about how you have felt since the last one: sleep, energy, digestion, mood, any flushing or headaches. The clinician sets up the line, starts at a conservative rate, and adjusts upward only if you are comfortable. Most patients settle into a routine by the second or third visit, once they know which sensations to mention and which to ignore.

An injection-based course is more distributed. Small doses might be spread over the week, which fits people who dislike long appointments but do not mind a routine. The trade is that the experience becomes part of daily life rather than a scheduled event, and adherence becomes the main challenge. People are generally more consistent with a short appointment they have booked than with a habit they have to remember.

Neither pattern is inherently better. What matters is that the schedule was chosen deliberately, with a defined review point, rather than continuing indefinitely because it was easy to rebook.

Safety and who should be careful

For most healthy adults, NAD+ delivered under medical supervision is generally well tolerated, and the most common problems are transient and related to rate or dose. Still, some situations call for caution or a conversation first.

Pregnancy and breastfeeding. Data are insufficient, so these are typically reasons to avoid.

Active cancer or a history of cancer. NAD+ supports cellular processes that could theoretically be used by tumor cells as well as healthy ones. Research is unsettled, and people with a cancer history should discuss this with their oncologist.

Significant heart, kidney, or liver disease. Infusions involve fluid volume and metabolism, so these conditions call for individual assessment.

Migraine, low blood pressure, or sensitivity to flushing. Rate control matters more, and some people prefer a slower or lower dose approach.

Medication interactions. Anyone on multiple prescriptions should review them before starting.

Injection-specific issues. Skin infections, bruising, or lumps at injection sites, and errors in self-administration, are the main practical risks.

As with any therapy, the question to ask is not whether it is safe in general but whether it is appropriate for you, with your history, at this dose, under this supervision.

Choosing between them: a scenario approach

Instead of a single recommendation, here are the situations where each route tends to make more sense.

You want a higher dose approach and are willing to invest time. An infusion fits, particularly if you want a structured series of sessions and clinical monitoring. People who use it often plan around a defined course rather than open-ended treatment.

You dislike sitting for hours or travel frequently. Injections may fit better because of speed and flexibility, provided you are comfortable with needles and the regimen is supervised.

You are needle-averse. Neither is a good fit, and oral precursors combined with lifestyle measures may be a more comfortable place to start.

You are new to NAD+ and unsure how you will respond. Beginning with a conservative approach, whichever route, and building slowly lets you learn your tolerance. Starting too high, too fast, is the most common way to have a bad first experience.

Your budget is limited. Injections are less expensive per session, but a realistic comparison considers the total monthly cost of a full protocol rather than the price of one dose.

You have a complex medical history. The clinic setting of an infusion provides monitoring, but the more important variable is a physician who knows your history and can pick the safest option, or advise against either.

Myths that come up in consultations

"More is always better." Higher doses are not automatically more effective, and pushing the dose is the fastest route to side effects. Response to NAD+ is not clearly linear, and many patients do well on moderate protocols.

"It works instantly for everyone." Some people notice a lift within days. Others notice nothing for weeks, and some do not respond noticeably at all. Individual variation is large, and that is normal.

"It replaces sleep, exercise, and food." It does not. NAD+ metabolism depends on the very habits people hope to shortcut. Someone sleeping five hours and drinking heavily will not offset that with a drip.

"A shot at home is the same as a clinic infusion." The molecule may be the same, but the dose, the delivery, the oversight, and the product sourcing are very different. Home injection can be reasonable when supervised and prescribed, but it is not a casual purchase.

"Everything labeled NAD+ is the same." Purity, concentration, and storage vary. Compounded products differ between pharmacies, which is why sourcing matters.

Questions to ask any clinic before you book

A few questions cut through the marketing.

Who prescribes and oversees treatment? A licensed physician who reviews your history is a baseline expectation. Our article on physician-led versus nurse-led clinics describes why this matters for therapies like this.

What is the dose, and how is the rate controlled? Vague answers are a red flag.

Where does the product come from? Ask about the compounding pharmacy and quality testing.

What outcomes will we track? Sensible practices set goals in advance, such as energy, sleep, exercise recovery, or lab markers, and check whether the therapy is helping. Broader biomarker tracking is discussed in our piece on longevity labs and healthspan biomarkers.

What happens if it does not help? A trustworthy practice will be ready to stop and rethink.

How to tell whether it is working

A therapy you cannot evaluate is a therapy you cannot justify. Before starting, decide what you would count as success and how you will check.

Subjective measures are a fair place to begin, provided they are recorded rather than remembered. A short weekly note on energy, afternoon focus, sleep quality, and recovery after workouts, scored from one to ten, is enough to reveal a pattern by week four or six. Wearable data on sleep and heart rate variability can add a rough objective layer, although the signals are noisy.

Lab markers can supplement the picture. Baseline and follow up glucose, insulin, lipids, inflammatory markers, and liver enzymes provide context, and some physicians track niacin metabolites or related markers. These do not prove a benefit, but they help detect problems and give structure to the conversation.

Set a review point, typically after a defined number of sessions or weeks. If you feel no difference and your markers are unchanged, the honest conclusion may be that this is not the right tool for you, and that is a useful finding rather than a failure.

What to do before and after

A few simple habits improve the experience regardless of route.

Eat something beforehand and stay hydrated, since an empty stomach can make nausea more likely. Tell the clinician about any medications, supplements, or recent illness. If you feel uncomfortable during an infusion, say so early, because a rate adjustment usually resolves it. After either format, note how you feel over the following days rather than relying on the first few hours, since responses can be delayed or subtle.

Consider pairing the therapy with the foundations that support NAD+ biology: adequate sleep, regular movement, moderate alcohol intake, and a diet that supplies the B vitamin precursors your body needs. Alcohol and chronic poor sleep can consume NAD+, and no infusion or injection will compensate for them.

Where NAD+ fits in a wider plan

NAD+ therapy is best viewed as one tool in a broader strategy for healthy aging, not a stand-alone solution. Patients who get the most out of it tend to have a defined reason, such as recovery from a demanding period, support for cognitive focus, or a specific longevity plan, and they pair it with measurement and lifestyle work.

Timing within a plan matters too. It usually makes more sense to sort out sleep, alcohol, thyroid function, iron, vitamin D, and blood sugar first, since any of these can produce the low energy that draws people toward NAD+ in the first place. If those are corrected and you still want to try it, you will have a much cleaner sense of what the therapy itself is doing.

Some patients find that NAD+ is a starting point that leads to deeper evaluation. If you are trying to sort out persistent fatigue in particular, our article on whether NAD IV therapy could be your energy solution discusses when it makes sense to look for causes first. And if you like the idea of injection-based therapies more broadly, peptide therapy and the evidence behind it offers a similarly candid appraisal.

At Liondale Medical, NAD+ is offered as part of a physician-led approach to longevity, not as a menu item. Dr. Lionel Bissoon reviews your history, discusses your goals, and helps you decide whether NAD+ makes sense and in which format. The practice's NAD+ program is built around supervised IV therapy, where the rate can be adjusted to your comfort and the session is monitored throughout.

Frequently Asked Questions

Are NAD+ injections as effective as NAD+ IV therapy?

They are not directly comparable. IV infusions usually deliver higher doses per session, while injections deliver smaller doses more often. There are no head-to-head trials showing one is superior, so the choice depends on your goals, comfort, and the protocol your physician recommends.

Do NAD+ shots hurt?

Many people feel stinging or burning at the injection site for a short time, and some notice redness or a small bruise. Injecting slowly, rotating sites, and using a smaller dose can reduce discomfort.

How long does an NAD+ IV take?

Sessions commonly last between one and four hours, depending on the dose. The infusion is run slowly because a fast rate can cause flushing, cramping, nausea, or chest tightness.

How often should you get NAD+ therapy?

It depends on the protocol. Some programs use a short series of infusions followed by periodic maintenance, while injection regimens may be weekly or more frequent. Your physician should set the schedule based on your goals and response.

Is NAD+ therapy safe?

For most healthy adults under medical supervision it is generally well tolerated, and common side effects are temporary and related to dose or rate. People who are pregnant, have a cancer history, or have significant heart, kidney, or liver disease should discuss it with a physician first.

Can I take NAD+ orally instead?

Oral NAD+ is largely broken down in the digestive tract, so oral products usually contain precursors such as nicotinamide riboside or NMN. These can raise NAD+ levels, though how that compares with IV or injected delivery has not been directly established.

This page was written and medically reviewed by Lionel Bissoon, D.O., founder of Liondale Medical. Dr. Bissoon is a board-certified osteopathic physician specializing in anti-aging and concierge medicine on the Upper West Side of Manhattan.

This content is for educational purposes only and does not constitute medical advice. Individual results may vary. Consult a qualified physician before beginning any new treatment.

Published September 29th, 2026